Emergent BioSolutions to Participate in Upcoming Investor Conferences

GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences:

• Wells Fargo 20th Annual Healthcare Conference
  September 4, 2025
  3:00 pm ET
  Webcast link here
  One-on-one meetings

• HCW 27th Annual Global Investment Conference
  September 9, 2025
  1:30 PM ET
  Webcast link here
  One-on-one meetings

Please contact your conference representative to request one-on-one meetings.

Participants can view the presentations and replays by visiting the Investors page of Emergent’s website.

About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threat, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.

Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
[email protected]  

Media Contact:
Assal Hellmer
Vice President, Communications
[email protected]

Source: Emergent BioSolutions

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Everbright Digital Holding Limited Announces Pricing of $8.07 Million Public Offering
• IT By Design to Host Executive AI Training at Build IT LIVE 2026
• Tzokamirel Reviews: Why Traders Are Talking About Tzokamirel AI Platform